Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1439 of 6351
-
New drug aims to restart periods in women with exercise-related amenorrhea
Disease control Recruiting nowThis study is researching an experimental drug called mibavademab (also called "study drug"). The study is focused on patients with a condition called Functional Hypothalamic Amenorrhea (FHA). FHA is a condition where a woman stops menstruating because the brain is not sending th…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New shot could tame rare bleeding disorder
Disease control Recruiting nowOpen-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of a single dose of sutacimig monotherapy in participants with congenital FVII deficiency (FVIID).
Phase 2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI blood test could spot lung cancer years earlier
Diagnosis Recruiting nowThis is a two-cohort (screen naïve vs screen established), prospective, longitudinal, single-center clinical study design that will provide data to comprehensively evaluate patient-reported outcomes of Artificial Intelligence (AI) based prediction of an individual's risk of devel…
Sponsor: University of Illinois at Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New scan may help match breast cancer patients to the right drug
Diagnosis Recruiting nowThis study aims to evaluate whether \^68Ga-TROP2 PET/CT, combined with \^18F-FDG PET/CT, can predict the efficacy of anti-TROP2 antibody-drug conjugates in patients with advanced HER2-negative breast cancer. Baseline and dynamic imaging parameters will be used to develop predicti…
Phase 2 • Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Blood filtering shows promise for chronic fatigue sufferers
Disease control Recruiting nowMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a severe, often infection-triggered disease characterized by debilitating fatigue and post-exertional malaise lasting over 14 hours, along with pain, cognitive impairment, autonomic dysfunction, and sleep disturbances…
Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Fewer hospital visits for cancer radiation? new trial tests shorter treatment
Symptom relief Recruiting nowThis study aims to evaluate a shorter course of postoperative pelvic radiotherapy in patients with cervical and endometrial cancer. The standard radiotherapy schedule usually requires many treatment sessions over several weeks, which can be burdensome for patients and may affect …
Sponsor: Siriraj Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Can an AI chatbot teach women to spot breast cancer risks?
Prevention CompletedThis study compared two educational approaches for increasing breast cancer awareness among female employees of Eskisehir Odunpazari Municipality. Participants were randomly assigned to receive education using artificial intelligence-generated educational material, education usin…
Sponsor: Eskisehir Osmangazi University • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a single robotic incision fix hernias with less pain and better looks?
Disease control Recruiting nowEvaluation of the perioperative outcomes of robotic suprapubic ventral hernia repair with the Da Vinci Singe Port (SP) system
Sponsor: Algemeen Ziekenhuis Maria Middelares • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a platelet gel boost gum healing without surgery?
Disease control Recruiting nowThis study aims to compare the clinical and radiographic effectiveness of injectable platelet-rich fibrin (i-PRF) combined with minimally invasive non-surgical therapy (MINST) versus MINST alone in the management of class II furcation defects.
Sponsor: October 6 University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a simple blood test replace the biopsy for prostate cancer?
Diagnosis Recruiting nowThis is a single center study evaluating whether a new blood test based on platelet proteins rather than plasma proteins can improve detection of prostate cancer and evaluate the degree of serious disease. Currently, doctors rely on multiple tests such as PSA, MRI scans and biops…
Sponsor: Duke University • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
New daily pill shows promise for Long-Term psoriatic arthritis control
Disease control Recruiting nowPsoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed th…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 10, 2026 05:00 UTC
-
Vitamin c boost: could high doses help fight bone marrow cancer?
Disease control Recruiting nowThis is an open-label, phase II clinical trial with safety run-in evaluating the safety, tolerability, and efficacy of IV HDA in combination with azacitidine for participants with MDS.
Phase 2 • Sponsor: Prajwal Dhakal • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Promising drug targets childhood eye muscle disease
Disease control Not yet recruitingUnder conventional treatment regimens, pediatric ocular myasthenia gravis (OMG) is prone to relapse and is associated with corticosteroid-related adverse effects, indicating an unmet clinical need. In May 2025, the targeted B-cell biologic agent Telitacicept was approved for use …
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New coaching program aims to delay dialysis for black kidney patients
Disease control Recruiting nowThrough the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients …
Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill aims to cut COPD attacks in half
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of RSS0343 tablets in patients with COPD. The study includes 3 study periods: a 4-week screening period, a 48-week treatment period, and …
Phase 2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New heart surgery technique aims to prevent silent strokes
Disease control Recruiting nowTo explore surgical strategies that reduce perioperative neurologic complications in cardiovascular surgery, with the aim of improving perioperative outcomes and quality of life while reducing the socioeconomic burden. Specifically: This multicenter, randomized controlled clinic…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill could slow blindness in inherited eye disease
Disease control OngoingThis integrated Ph1/2 clinical study is to assess the safety, tolerability and pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of OCT-980 in healthy volunteers and participants with RHO-adRP.
Phase 1/2 • Sponsor: Octant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple pacemaker setting ease right heart failure?
Disease control Not yet recruitingThis study is a prospective, single-arm, target value clinical trial. We plan to prospectively enroll and follow 24 patients across three centers nationwide who have a low baseline heart rate (HR ≤ 60 bpm), meet the indication for permanent pacemaker implantation, and have right-…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to slow progressive MS disability
Disease control Recruiting nowThe main purpose of this study is to assess the efficacy of RO7268489 in adults with progressive multiple sclerosis (PMS) receiving ocrelizumab. After the end of the double-blind period, an open-label (OL) extension may allow eligible participants to receive open-label RO7268489.
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hope for PCOS: supplement combo aims to restore ovulation
Disease control Recruiting nowThis study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical out…
Phase 3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC